Phase 0/1 Biomarker and Pharmacodynamic Study of Roflumilast in Patients With Advanced B-Cell Hematologic Malignancies (CTRC# 13-0013)

NCT01888952 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Advanced B-cell Lymphoid Malignancies

Interventions

DRUG: Prednisone
DRUG: Roflumilast

Sponsor

Anand B. Karnad